Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm established in 2006 and headquartered in Shanghai, with additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early to growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology in China. Since its inception, Qiming has built a reputation as a leading investment firm in the region, managing multiple funds with over $1 billion in assets. The firm aims to support promising entrepreneurs and innovative businesses, contributing to the development of China's dynamic economic landscape.

Artavazd Arumov Ph.D

Principal

Ryan Baker

Chief Financial Officer

Sam Chen

Associate

Nan Chen

Principal

Phil DiGiacomo

VP

Anna French

Partner

Jinda Gao

Executive Director

William Hu

Managing Partner

Duane Kuang

Co-Founder & Managing Partner

Grace Lee

Partner

Nisa Leung

Managing Partner

Shuo Mao

vice_president

Mark McDade

Partner

Will Mcconnell

VP

Gary Rieschel

Co-Founder & Managing Partner

Amy Tang

Venture Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Jing Wu

Partner

Kuantai Yeh

Partner

Janet Yu Ph.D

Partner

Oscar Zhang

Principal

Alex Zhou

Partner

Past deals in Asia Pacific

Bioyond Tech

Series A in 2023
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

DeepWay

Series A in 2023
Deepway is a smart vehicle manufacturer that provides intelligent driving solutions for the truck freight market. The company provides heavy-duty trucks with low wind resistance bodies, intelligent driving, distributed drive system with modular design based on the same hydrogen and electricity platform, allowing the logistics industry to benefit from smart freight system.
Hochuen Medical was founded in 2015 by Dr. Robin Liu, an entrepreneur in IVD medical and microfluidics fields, and Eric Zeng, an expert in the electronics OEM industry. The founding management team has an average of more than 20 years of management experience in manufacturing of microfluidic devices, medical disposables, and consumer electronic products. Dr. Robin Liu, co-founder and president of Hochuen Medical, has more than 20 years of experience in the IVD and microfluidic industry, with experience at Motorola, CombiMatrix, GenMark, Beckman Coulter/Danaher, etc. Dr. Liu brings both experience in R&D and production management in the fields of molecular diagnosis, immunoassays, hematology, urinalysis, etc

Yike Polymers

Series B in 2023
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.

CSR Biotech

Seed Round in 2022
Guangzhou Chaoshiji Biotechnology Co., Ltd. (Chaoshiji Technologies) is a high-tech company specializing in the creation and deployment of super-resolution imaging devices for living cells. R&D, production, sales, after-sales, and technical output services for various types of super-resolution optical microscopes are the primary activities. Among the services offered are customized cell sample generation, customized cell sample high-throughput detection, customized cell sample imaging studies, and customized image post-processing and quantitative analysis.

DeepWay

Series A in 2022
Deepway is a smart vehicle manufacturer that provides intelligent driving solutions for the truck freight market. The company provides heavy-duty trucks with low wind resistance bodies, intelligent driving, distributed drive system with modular design based on the same hydrogen and electricity platform, allowing the logistics industry to benefit from smart freight system.

CIX Technology

Seed Round in 2022
CIX Technology develops high-performance, next-generation intelligent computing solutions.

Gaugene

Series B in 2022
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Biotree

Series A in 2022
Shanghai Biotree biotech Co., Ltd. engages in the development of life science research technology application. The company application is used for sample testing, big data analysis, and technical product development in the field of life sciences, as well as to provides professional services. It serves universities, research institutes, hospitals, and enterprises. The company was founded in 2013 and is based in Shanghai, China.

Ark Biosciences

Series D in 2022
Ark Biosciences Inc., a biopharmaceutical company, discovers and develops therapeutics to address unmet medical need in the areas of respiratory viral infection and viral hepatitis for worldwide markets. Its products include AK0701 for Chronic obstructive pulmonary disease (COPD), AK0529 for Respiratory syncytial virus (RSV), AK0612 for Influenza, and AK0705 and AK0706 for Hepatitis B. The company was founded in 2013 and is based in Shanghai, China.

LaNova Medicines

Series B in 2022
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is an artificial intelligence company based in Rockville, Maryland, specializing in drug discovery, biomarker development, and aging research. Founded in 2014, the company leverages advanced AI techniques, including generative adversarial networks and deep learning, to create novel molecular structures for various diseases. Insilico Medicine has developed a comprehensive end-to-end pipeline for drug discovery, which encompasses all stages from initial research to clinical trials. Its notable platforms include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, which integrates predictors of age. The company is actively engaged in internal drug discovery programs targeting conditions such as cancer, Alzheimer's disease, and diabetes. Additionally, Insilico Medicine has partnered with Life Extension to produce nutraceutical products using bioinformatics and deep learning. It serves a diverse clientele, including academia, pharmaceutical companies, and cosmetic firms, while also providing consumer-facing applications to enhance health and longevity.

BUD

Series B in 2022
Founded in 2019 by former Snap engineers, Risa Feng and Shawn Lin, Singapore-headquartered BUD is a leading global metaverse UGC platform encouraging users to create and share 3D interactive experiences with its easy-to-use creation tools. Since its global launch in November 2021, BUD skyrocketed to the list of top 10 social apps in more than 38 countries around the world including North America, Southeast Asia and South America. Millions of 3D content has been created and traded on the platform. BUD has become a digital social hub where millions of people come to create, play and hangout.

Yike Polymers

Series B in 2022
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.

CIX Technology

Angel Round in 2022
CIX Technology develops high-performance, next-generation intelligent computing solutions.

Houmo.AI

Series A in 2022
Houmo.AI is a semiconductor company that develops an integrated circuit storage technology for AI computing. The company aims to use disruptive technologies to create AI chips with a "ten-fold effect", to meet the huge computing power demand in the era of true artificial intelligence, and to use unlimited computing power to change the world. Houmo.AI was founded by Dr. Wu Qiang in 2020.

MeetFuture China

Series B in 2022
MeetFuture China is a technology-driven company that supplies automated transmission systems for the pan-semiconductor industry. It provides automation solutions for leading companies in the semiconductor field since 2016 and provided a highly advantageous overall for industrial upgrading and development with independent and controllable core technologies.

BlockVision

Seed Round in 2022
BlockVision is a high-availability indexing network, supporting complex queries and data storage across multiple blockchains such as Ethereum, BNB Chain, Arbitrum, Optimism, and more.

GluBio Therapeutics

Series A in 2022
GluBio Pharmaceutical focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.

Prime Lifescience

Seed Round in 2022
Prime Lifescience is a developer of a big data platform that focuses on life sciences. The company is dedicated to establishing a health lifecycle big data collaboration network through digital technology innovation and extensive use of artificial intelligence. They offer a digital smart health community, a digital intelligent clinical research accelerator, and a live big data platform as part of their offering.

Wowjoy Technology

Series A in 2022
Wowjoy Technology develops a platform to provide data-driven medical services. The firm is headquartered in Hangzhou, China.

NFTGo

Seed Round in 2022
NFTGo is a NFT data aggregator where users can find information about NFT, including NFT Drops, ranking, whale tracking, NFT search engine, market data, transaction data, and many more.

Deep View Technology

Series B in 2022
Beijing Deep View Technology Co., Ltd. engaged in research on 3D computer vision algorithm. The company is based in Beijing, China.

EigenCOMM

Series C in 2022
Eigencomm is dedicated to the development and sales of cellular IoT chips.

Zhenge Biotech

Series C in 2022
Shanghai ZhenGe Biotechnology Co.,Ltd. researches and develops drugs. It also engages in mammalian cell line development, upstream development, downstream development, and formulation development for various protein therapeutics. In addition, the company provides contract development and manufacturing services; and offers IND and BLA filing services. Further, it provides platform for research and development of antibodies, transient infection, process development, N-Glycosylation, and CAR-T. Shanghai ZhenGe Biotechnology Co.,Ltd. was founded in 2017 and is based in Shanghai, China.

CureGenetics

Series B in 2022
CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

MKSEMI

Series A in 2022
Provider of high precision location technology IC and solutions. The company focuses on developing high performance, low-power, and highly integrated IC and provides solutions in smartphones, wearables, digital health, smart home and general IoT applications.

DPTechnology

Series B in 2021
DPTechnology, founded in 2018 and based in Beijing, China, specializes in micro-scale industrial design through advanced molecular simulation technology. The company has developed a platform that integrates artificial intelligence with molecular simulation algorithms, aiming to enhance industrial and medical research. By providing users with innovative scientific tools, DPTechnology promotes efficiency and creativity in exploring complex research challenges, thereby establishing a new paradigm in both industrial research and clinical applications.

Yunji Technology

Venture Round in 2021
Yunji Technology is a Chinese robot company that builds a commercial service robot capable of delivering goods.

Xinchuangyuan Semiconductor

Series A in 2021
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment. Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.

Superhexa

Series A in 2021
Superhexa is a cutting-edge hardware firm that specializes in personal consumer electronics. Superhexa was founded at October 15, 2020 by Xia Yongfeng and is located in Beijing.

Gemsouls

Series A in 2021
Gemsouls is an AI technology that powers virtual characters and their interactions with the real world. Headquarterd in Shanghai.

Tripod Preclinical Research

Venture Round in 2021
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics,pesticides,veterinary drugs, and new cosmetics.

Shanzhen

Series D in 2021
ShanZhen provides access to affordable regular health checkups, as well as personalized health management plans and insurance.

Zeen Health

Venture Round in 2021
Zeen Health is a digital therapeutics company that provides mental health services. Zeen Health was founded in 2019 and was headquartered in Shenzhen, China.

Atom Semiconductor

Venture Round in 2021
Atom Semiconductor is a scientific and technological enterprise focusing on digital sensor design. Atom Semiconductor was founded in 2020.

Supermag

Series A in 2021
Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as Suci Technology) is committed to the research and development, production and sales of maglev high-speed motors. With the design authorization of magnetic levitation compressors, magnetic levitation blowers, magnetic levitation pumps, etc., it provides core components such as magnetic levitation motors, magnetic levitation bearings, magnetic levitation controllers, and displacement sensors.

Bioyond Tech

Seed Round in 2021
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Genlight

Series B in 2021
Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.

Qingflow

Series B in 2021
Qingflow is a software-as-a-service platform that enables users to create management systems. Qingflow is located in Minhang District, Shanghai.

Brise Pharma

Angel Round in 2021
Brise Pharma operates in the scientific research and technical service industry.

Sunyur

Series B in 2021
Sunyur is an e-purchase solution provider.

BUD

Series A in 2021
Founded in 2019 by former Snap engineers, Risa Feng and Shawn Lin, Singapore-headquartered BUD is a leading global metaverse UGC platform encouraging users to create and share 3D interactive experiences with its easy-to-use creation tools. Since its global launch in November 2021, BUD skyrocketed to the list of top 10 social apps in more than 38 countries around the world including North America, Southeast Asia and South America. Millions of 3D content has been created and traded on the platform. BUD has become a digital social hub where millions of people come to create, play and hangout.

V Light

Series A in 2021
V Light is an interest social app.

moodytiger

Series B in 2021
Moody Tiger is an international activewear brand for children. Moody Tiger was founded in 2018.

Gyenno Science

Series B in 2021
Developer of intelligent medical devices designed for treatment of Parkinson and motor dysfunction. With research and development of intelligent monitoring and assistant devices, the company develops systematic systematic solutions to functional disorders for patients with Parkinson and motor dysfunction, enabling patients to monitor their physical activities and facilitate their movements.

Wowjoy Technology

Series A in 2021
Wowjoy Technology develops a platform to provide data-driven medical services. The firm is headquartered in Hangzhou, China.

Lingyi Zhihui

Series B in 2021
Zuoshouyisheng's AI ​​doctor platform spans 35 medical specialties and can diagnose more than 6,000 diseases, according to the company’s website. Zuoshouyisheng mainly collaborates with customers through a SaaS business model, providing its AI-empowered healthcare system to hospitals, pharmaceutical companies, employers, and insurers.

Houmo.AI

Seed Round in 2021
Houmo.AI is a semiconductor company that develops an integrated circuit storage technology for AI computing. The company aims to use disruptive technologies to create AI chips with a "ten-fold effect", to meet the huge computing power demand in the era of true artificial intelligence, and to use unlimited computing power to change the world. Houmo.AI was founded by Dr. Wu Qiang in 2020.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Berry Oncology

Series B in 2021
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

WeRide

Secondary Market in 2021
Guangzhou WeRide Technology Co., Ltd. develops autonomous driving technology for level 4 AD cars. The company also develops own AD hardware solution to fit on cars for surround sensor coverage and full spectrum. The company was founded in 2017 and is headquartered in Guangzhou, China.

Superhexa

Seed Round in 2021
Superhexa is a cutting-edge hardware firm that specializes in personal consumer electronics. Superhexa was founded at October 15, 2020 by Xia Yongfeng and is located in Beijing.

Yunqi

Seed Round in 2021
Yunqi is an efficient cloud e-commerce business platform that distributes software products and technical services. Yunqi provides ways to do business in different sales channels. It also provides systems and services to help businesses do business in various modes.

Neuro3 Therapeutics

Seed Round in 2021
Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.

Petkit

Series D in 2021
Shanghai PETKIT Network Technology Co., Ltd. Develops and manufactures pet care products. It offers smart antibacterial bowls, smart feeders, smart drinking fountains, pet accompanying cups, smart leashes, smart cat brand dog tags, smart pet companions, multifunctional cat claw plates, etc.; cat and dog tags that record, analyze, and track the pet's usual sports behavior data; and toys. Shanghai PETKIT Network Technology Co., Ltd. was founded in 2013 and is based in Shanghai, China.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.

NEIWAI

Series D in 2021
NEIWAI is a mid-to-high-end underwear brand founded in Shanghai in 2012, dedicated to providing comfortable clothing that respects the feelings of women. The company emphasizes a design philosophy that harmonizes comfort, function, and beauty, resulting in a diverse range of products suitable for various daily activities, including home and sports. Over the past five years, NEIWAI has served more than 200,000 female customers, reflecting its commitment to meeting the needs of its clientele. By focusing on the comfort of close-fitting clothing, NEIWAI aims to enhance the everyday experiences of its customers through thoughtfully designed underwear.
Hochuen Medical was founded in 2015 by Dr. Robin Liu, an entrepreneur in IVD medical and microfluidics fields, and Eric Zeng, an expert in the electronics OEM industry. The founding management team has an average of more than 20 years of management experience in manufacturing of microfluidic devices, medical disposables, and consumer electronic products. Dr. Robin Liu, co-founder and president of Hochuen Medical, has more than 20 years of experience in the IVD and microfluidic industry, with experience at Motorola, CombiMatrix, GenMark, Beckman Coulter/Danaher, etc. Dr. Liu brings both experience in R&D and production management in the fields of molecular diagnosis, immunoassays, hematology, urinalysis, etc

Kingsware

Series B in 2021
Kingsware specializes in developing a robotic process automation system. It is committed to building an enterprise-level safe robot management platform. Its product follows the design concept of safe, easy-to-use, powerful, stable, and efficient, and the system can be deployed and controlled in a large-scale, highly integrated enterprise complex environment.

Insilico Medicine

Series C in 2021
Insilico Medicine, Inc. is an artificial intelligence company based in Rockville, Maryland, specializing in drug discovery, biomarker development, and aging research. Founded in 2014, the company leverages advanced AI techniques, including generative adversarial networks and deep learning, to create novel molecular structures for various diseases. Insilico Medicine has developed a comprehensive end-to-end pipeline for drug discovery, which encompasses all stages from initial research to clinical trials. Its notable platforms include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, which integrates predictors of age. The company is actively engaged in internal drug discovery programs targeting conditions such as cancer, Alzheimer's disease, and diabetes. Additionally, Insilico Medicine has partnered with Life Extension to produce nutraceutical products using bioinformatics and deep learning. It serves a diverse clientele, including academia, pharmaceutical companies, and cosmetic firms, while also providing consumer-facing applications to enhance health and longevity.

Hesai Technology

Series D in 2021
Hesai Technology designs a laser radar that facilitates autonomous driving. It uses smart sensing technology to develop laser radar for autonomous cars and natural gas leak detection systems, enabling car companies to monitor mixed gas composition, control industrial processes and detect hazardous gas leaks.

IntoCare

Series D in 2021
IntoCare is a high-tech company focused on the development of advanced medical devices for surgical procedures. The company specializes in powered surgical staplers, offering both reusable and disposable stapler handles. IntoCare aims to enhance surgical practices by providing reliable, intelligent, and user-friendly instruments. Through its research and development efforts, the company seeks to advance the field of surgical technology and support the marketing of nonpharmaceutical interventions, ensuring that healthcare professionals have access to innovative tools that improve patient outcomes.

Health Biotech

Series B in 2021
Beijing Health Biotech Co. Ltd. develops diagnostic and therapeutic products for diagnosis, treatment, and monitoring of Alzheimer's disease. The company offers diagnostic and therapeutic products, such as vitamins detection, Alzheimer's disease detection and treatment, prostate AA detection, ceramides test, therapeutic drug monitoring, and screening of neonatal genetic metabolic diseases for Alzheimer's disease, cardiovascular disease, urinary disease, genetic metabolic disease, therapeutic drug monitoring, metabolite detection, steroid hormone detection, trace element quantitative detection, vitamin family detection, and microbiological identification. It also offers clinical testing and research services. The company was founded in 2016 and is based in Beijing, China.

MKSEMI

Series A in 2021
Provider of high precision location technology IC and solutions. The company focuses on developing high performance, low-power, and highly integrated IC and provides solutions in smartphones, wearables, digital health, smart home and general IoT applications.

Data Transmission Group

Secondary Market in 2021
Data Transmission Group is an Internet technology group focusing on big data services in the press and publishing industry. Data Transmission Group is committed to the digital transformation and upgrading of big data services in the press and publication industry and the digital transformation and upgrading of the media industry, creating a digital content profit model with content providers as the main commercial value, changing the way users acquire and disseminate knowledge, and leading the Internet + upgrade of China's news and publications Replacement and industrial development direction. At present, the group has nearly 200 employees, most of whom are senior publishing, Internet, and software R&D personnel. They have a complete independent R&D system and have rich research results in mobile Internet technology, storage technology, data mining, and publishing integration.

MeetFuture China

Series A in 2021
MeetFuture China is a technology-driven company that supplies automated transmission systems for the pan-semiconductor industry. It provides automation solutions for leading companies in the semiconductor field since 2016 and provided a highly advantageous overall for industrial upgrading and development with independent and controllable core technologies.

Just Medical

Series B in 2021
Just Medical is an artificial orthopedic implant device and system developer.

Hope Medicine

Series B in 2021
Hope Medicine focuses on researching, developing, and commercializing innovative biopharmaceuticals aimed at enhancing the quality of life for patients with various prevalent diseases. The company specializes in translational medicine, utilizing insights from global research initiatives to create monoclonal antibodies, protein drugs, and other therapeutic options targeting endocrine, cardiovascular, and metabolic disorders. By addressing the needs of underserved patient populations, Hope Medicine strives to improve health outcomes and provide access to effective and affordable treatments.

Yidao Biotechnology

Series C in 2021
Yidao Biotechnology research and develops vaccines and biomedical products. It focuses on the research and development of a variety of vaccines such as recombinant protein antigen vaccine, new virus vector vaccine, messenger RNA vaccine, and vaccine adjuvant platforms, providing vaccines to meet the needs of human health in both domestic and international markets. The Suzhou, Jiangsu-based biotech company was established in 2017.

Tasogare

Series B in 2021
Tasogare Coffee is a Japan-based company specializing in the distribution of high-quality coffee. The company's focus is on providing premium coffee products to customers, ensuring a commitment to quality in its offerings. Through careful sourcing and distribution practices, Tasogare aims to deliver a superior coffee experience.

Matrixport

Series C in 2021
Matrixport is your gateway to digital economy where you can trade, custody, invest and borrow crypto assets all in one stop. With rich industry resources and leading technology capabilities, Matrixport aims to create the next generation digital financial service platform. Their vision is to enable a more open and equal financial system using blockchain technologies. Matrixport has launched trading, digital asset custody, and cryptocurrency lending service for clients around the world, with even more innovative product offerings to come. Matrixport is headquartered in Singapore with offices worldwide.

Gaugene

Series A in 2021
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Xizi Education

Series A in 2021
Xizhi Education (Beijing Xizi Education Technology Co., Ltd.) is a leading enterprise in artificial intelligence empowerment education. The headquarters is located in Zhizhi Street, Zhongguancun, which is known as the “China Silicon Valley”. As one of the key incubators of Tsinghua University, from the aspects of policy, capital and talents, it has been strongly supported by Tsinghua's three innovation and entrepreneurship platforms iCenter, Chuang+ and xlab, and won the honor of Zhongguancun High-tech Enterprise.

Sincere Edu

Series A in 2021
Sincere Edu is an online financial professional education brand. With CPA exam training as its entry point, it is committed to building a learning and growth platform that can accompany professional financial professionals throughout their careers. Sear Education hopes to truly meet the various needs of students by reconstructing the models and products of the financial professional education market; through the wisdom sharing and the cultivation of the teacher training system

Zion Pharma

Series B in 2021
Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.

imToken

Series B in 2021
imToken Pte. Ltd. is a Singapore-based company that specializes in developing a blockchain-based cryptocurrency wallet and digital asset management tools. Founded in 2016, imToken enables users to manage multi-chain assets and facilitates secure token exchanges within its wallet. The platform features a DApp browser that supports decentralized token-to-token transactions, enhancing the user experience in the blockchain ecosystem. Over the years, imToken has garnered a global user base, becoming one of the largest Ethereum wallets in the world. The company operates as a subsidiary of Hangzhou Rongshi Technology Co., Ltd. and is dedicated to making blockchain technology accessible and user-friendly for a broader audience.

Zhenge Biotech

Series B in 2021
Shanghai ZhenGe Biotechnology Co.,Ltd. researches and develops drugs. It also engages in mammalian cell line development, upstream development, downstream development, and formulation development for various protein therapeutics. In addition, the company provides contract development and manufacturing services; and offers IND and BLA filing services. Further, it provides platform for research and development of antibodies, transient infection, process development, N-Glycosylation, and CAR-T. Shanghai ZhenGe Biotechnology Co.,Ltd. was founded in 2017 and is based in Shanghai, China.

Cool Academy

Series B in 2021
Cool College is a Beijing-based software-as-a-service(SaaS) developer for employee training services.

Medilink-Global

Series A in 2021
Medilink-Global provides third-party administration solutions to health insurance and corporate organizations.

Newsoara

Venture Round in 2021
Newsoara is a biomedical technology developer that specializes in the development of medical devices.

Casela

Series A in 2021
Casela is a chip and semiconductor company

IntoCare

Secondary Market in 2021
IntoCare is a high-tech company focused on the development of advanced medical devices for surgical procedures. The company specializes in powered surgical staplers, offering both reusable and disposable stapler handles. IntoCare aims to enhance surgical practices by providing reliable, intelligent, and user-friendly instruments. Through its research and development efforts, the company seeks to advance the field of surgical technology and support the marketing of nonpharmaceutical interventions, ensuring that healthcare professionals have access to innovative tools that improve patient outcomes.

Yuanbao Tech

Series C in 2021
Beijing Yuanbao Technology Co., Ltd., a technology company, provides cyber security assessment consulting, network security detection, and cyber security insurance solutions. It offers network security risk monitoring and evaluation, and network security defense system construction advisory services; risk assessment and risk mitigation solutions; model development and technical services for cyber security insurance products for insurance and reinsurance companies; assists insurance companies to conduct cyber security risk assessment for insured customers. The company was founded in 2018 and is based in Beijing, China.

XSKY Data Technology

Series E in 2021
XSky (Beijing) Data Technology Co., Ltd. is a Chinese company specializing in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS for cloud storage, XEBS for block storage, XEUS for unified storage, XEOS for object storage, and XEDP as a unified data platform. The company also provides software-defined storage solutions with its XSCALER series. XSky serves various sectors, including finance, healthcare, education, telecommunications, and energy, catering to enterprises, government agencies, and media networks. In addition to its product offerings, XSky is a significant contributor to the open-source storage system Ceph and is recognized as a leading partner of Red Hat in China. The company collaborates with major IT firms like Intel and Dell to enhance its technology and solutions, focusing on scalable and future-ready storage options.

Delta Medical

Series E in 2021
Beijing Delta Medical Co., Ltd. designs and manufactures sports medicine surgical instruments, intraoperative consumables and rehabilitation products. It offer products, such as shoulder arthroscopic instrument, PEEK suture anchor, titanium suture anchor, anterior cruciate ligament and posterior cruciate ligament reconstruction instrument, PEEK interference screw, titanium interference screw, ultra high speed fiber, ultra high speed fiber tape, needle loop, shaver system, arthroscopic hand instrument, medical face shield, and medical eye shield. It also provides sports rehabilitation services. The company is based in Beijing, China.

Singular Medical

Series B in 2021
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.

Miaoshou Doctor

Series E in 2021
Miaoshou Doctor is a healthcare service platform for building an online communication service platform between patients and doctors. It helps healthcare professionals and patients to manage post-diagnosis outcomes and allows doctors to actively follow up with their patient's health through additional counseling and prescriptions. Tao He and Daoliang Han founded the company in 2015 and is based in Beijing, Beijing.